clinical trial · NCT05478304
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
AtriCure, Inc.·N/A·active not recruiting·n = 6,573
Ischemic StrokeSystemic EmbolismAtriClip LAA Exclusion System
brief summary
This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.
started
Jan 25, 2023
primary completion
Dec 1, 2031
completion
Apr 1, 2032
last updated
Mar 24, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol